.
.
.
.

COVID-19 jab maker BioNTech to build factory in Singapore

Published: Updated:

COVID-19 jab maker BioNTech said Monday it would build a factory in Singapore that could produce hundreds of millions of doses of vaccines based on its mRNA technology per year in southeast Asia.

For more coronavirus news, visit our dedicated page.

Construction of the manufacturing plant and a regional headquarters in Singapore will start this year, and the site could become operational by 2023, the German company said in a statement.